Catheter System Designed to Provide Peripheral Vascular Access “When
a PIV is Not Enough and a PICC is Too Much”
WAYNE, Pa.--(BUSINESS WIRE)--Jul. 29, 2015--
Teleflex Incorporated (NYSE:TFX), a global provider of medical devices
for critical care and surgery, announced today that its ARROW Endurance™
Extended Dwell Peripheral Catheter System received market clearance from
the U.S. Food and Drug Administration (FDA).
The new device is a peripheral catheter system in which the catheter is
cleared by the FDA to dwell up to 29 days. The extended dwell catheter
enables hospitals to avoid using multiple PIVs to achieve longer dwell
times while also avoiding the extra clinical risks and expenses
associated with a peripherally inserted central catheter (PICC). The
intravascular catheter is intended for short-term use (up to 29 days) to
permit delivery of infusion therapies, pressure monitoring, high
pressure injection (325 psi max.), and withdrawal of blood.
“The ARROW Endurance™ Extended Dwell Peripheral Catheter System is yet
another offering from Teleflex that helps vascular access professionals
provide the right line for the right patient at the right time,” said
Jay White, president of Teleflex's Vascular Access Division. “This is
the ideal solution when patients need IV therapy for more than the few
days that a traditional PIV allows but don’t require a PICC.”
Designed to maximize performance and ease-of-use, the extended dwell
system is engineered to increase safety for clinicians and reduce needle
sticks for patients. The device contains a passive needle safety that
reduces the risk of accidental needle stick injuries and exposure to
blood. The closed system design makes it less likely that clinicians
will accidentally come in contact with bloodborne pathogens.
Teleflex expects to launch the ARROW Endurance™ Extended Dwell
Peripheral Catheter System in the United States later this year.
To learn more about the Arrow® Vascular portfolio from Teleflex, please
visit ArrowVascular.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 12,200 people and serves healthcare
providers worldwide. For additional information about Teleflex please
refer to www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, Arrow, and Arrow Endurance are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates. © 2015 Teleflex
Incorporated. All rights reserved. MC-001435
View source version on businesswire.com: http://www.businesswire.com/news/home/20150729005018/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com